Prionic diseases.

Area of Science:

• Neuroscience
• Pathology

Background:

• Prion diseases are fatal neurodegenerative disorders characterized by the accumulation of abnormal prion proteins.
• These diseases, including Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker (GSS) syndrome, and fatal familial insomnia (FFI), are caused by infectious protein pathogens lacking nucleic acid.
• Prions exhibit unique resistance to standard decontamination methods.

Purpose of the Study:

• To review the nature, causes, clinical presentation, diagnosis, and outcomes of prion diseases.
• To highlight the link between PRNP gene mutations and familial prionopathies.
• To emphasize the diagnostic challenges and current limitations in treating these conditions.

Main Methods:

• Review of existing literature on prion diseases.
• Analysis of clinical features, diagnostic methods (MRI, 14-3-3 protein, tonsil biopsy, genetic studies), and histopathology.
• Discussion of the role of the prion protein gene (PRNP) and its mutations.

Main Results:

• Prion diseases result from the accumulation of abnormal prion protein isoforms in the brain, leading to neuronal apoptosis.
• A strong correlation exists between PRNP gene mutations and familial forms of prion disease.
• While in vivo diagnostic tools exist, histopathology remains the definitive diagnostic method.

Conclusions:

• Prionopathies are rapidly progressive, fatal neurodegenerative diseases with no effective treatments currently available.
• Early clinical suspicion is crucial, especially in cases of rapidly progressing dementia, ataxia, myoclonus, or pathological insomnia.
• Further research into effective treatments for these devastating diseases is urgently needed.